Published in Science on July 02, 1993
Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol (2000) 8.89
Displacement of an E-box-binding repressor by basic helix-loop-helix proteins: implications for B-cell specificity of the immunoglobulin heavy-chain enhancer. Mol Cell Biol (1994) 2.15
The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol (1994) 1.99
A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions. Mol Cell Biol (1998) 1.93
Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol Cell Biol (1996) 1.85
Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins. J Virol (1995) 1.80
Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J (1997) 1.73
An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. Genes Dev (2002) 1.73
Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1. Mol Cell Biol (1998) 1.69
ERP, a new member of the ets transcription factor/oncoprotein family: cloning, characterization, and differential expression during B-lymphocyte development. Mol Cell Biol (1994) 1.67
Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol (1996) 1.63
Ets proteins: new factors that regulate immunoglobulin heavy-chain gene expression. Mol Cell Biol (1993) 1.54
Real-time DNA binding measurements of the ETS1 recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms. Protein Sci (1994) 1.44
Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export. Mol Cell Biol (2000) 1.44
Matrix attachment region-dependent function of the immunoglobulin mu enhancer involves histone acetylation at a distance without changes in enhancer occupancy. Mol Cell Biol (2001) 1.28
Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer. Mol Cell Biol (1994) 1.26
A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J Virol (1994) 1.26
c-Maf interacts with c-Myb to regulate transcription of an early myeloid gene during differentiation. Mol Cell Biol (1998) 1.25
Activation of transcription by PU.1 requires both acidic and glutamine domains. Mol Cell Biol (1996) 1.22
Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator. Mol Cell Biol (1999) 1.21
Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Mol Cell Biol (1998) 1.19
A potential role for Elf-1 in terminal transferase gene regulation. Mol Cell Biol (1996) 1.10
The V(D)J recombinational and transcriptional activities of the immunoglobulin heavy-chain intronic enhancer can be mediated through distinct protein-binding sites in a transgenic substrate. Mol Cell Biol (1995) 1.09
Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1. Mol Cell Biol (1996) 1.09
Multiple motifs regulate the B-cell-specific promoter of the B29 gene. Proc Natl Acad Sci U S A (1993) 1.06
The transcription factor PU.1 is involved in macrophage proliferation. J Exp Med (1996) 1.05
The human beta 2 integrin CD18 promoter consists of two inverted Ets cis elements. Mol Cell Biol (1994) 1.05
Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-Ets-1 domain. Mol Cell Biol (1995) 1.04
PU.1 and an HLH family member contribute to the myeloid-specific transcription of the Fc gamma RIIIA promoter. EMBO J (1994) 1.04
Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor. Mol Cell Biol (1994) 1.03
Pax5 (BSAP) regulates the murine immunoglobulin 3' alpha enhancer by suppressing binding of NF-alpha P, a protein that controls heavy chain transcription. Proc Natl Acad Sci U S A (1995) 1.02
Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression. Mol Cell Biol (1997) 1.01
The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Am J Pathol (2001) 1.01
Properties of ets-1 binding to chromatin and its effect on platelet factor 4 gene expression. Mol Cell Biol (2004) 0.99
Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer. Mol Cancer (2007) 0.99
Precise alignment of sites required for mu enhancer activation in B cells. Mol Cell Biol (1996) 0.97
Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells. Mol Cell Biol (1995) 0.96
PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis. J Cell Mol Med (2009) 0.96
Transcriptional activation by ETS and leucine zipper-containing basic helix-loop-helix proteins. Mol Cell Biol (1999) 0.96
Definition of a T-cell receptor beta gene core enhancer of V(D)J recombination by transgenic mapping. Mol Cell Biol (2000) 0.95
ETS-core binding factor: a common composite motif in antigen receptor gene enhancers. Mol Cell Biol (1998) 0.95
Mechanism of e47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts. Mol Cell Biol (2002) 0.94
Inhibition of p300/CBP by early B-cell factor. Mol Cell Biol (2003) 0.94
ETS-mediated cooperation between basic helix-loop-helix motifs of the immunoglobulin mu heavy-chain gene enhancer. Mol Cell Biol (1998) 0.93
Combinatorial determinants of tissue-specific transcription in B cells and macrophages. Mol Cell Biol (1997) 0.92
ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques. Proc Natl Acad Sci U S A (1997) 0.92
Context dependent transactivation domains activate the immunoglobulin mu heavy chain gene enhancer. EMBO J (1996) 0.92
Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality. Exp Hematol (2007) 0.89
Cell-specific association and shuttling of IkappaBalpha provides a mechanism for nuclear NF-kappaB in B lymphocytes. Mol Cell Biol (2001) 0.89
Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J Virol (1994) 0.89
Ets-1 activates the DRA promoter in B cells. Mol Cell Biol (1994) 0.88
Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity. Nucleic Acids Res (2005) 0.86
Exploring functional redundancy in the immunoglobulin mu heavy-chain gene enhancer. Mol Cell Biol (1998) 0.82
Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus. J Cell Sci (2005) 0.80
The E47 transcription factor binds to the enhancer sequences of recombinant murine leukemia viruses and influences enhancer function. J Virol (1995) 0.78
Mi2beta shows chromatin enzyme specificity by erasing a DNase I-hypersensitive site established by ACF. J Biol Chem (2009) 0.76
Interaction between E-protein and Oct transcription factors in the function of the catfish IGH enhancer. Dev Comp Immunol (2008) 0.76
The antiproliferative ELF2 isoform, ELF2B, induces apoptosis in vitro and perturbs early lymphocytic development in vivo. J Hematol Oncol (2017) 0.75
PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4. Oncogene (2017) 0.75
Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma. Oncogene (2017) 0.75
Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell (1986) 20.08
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell (1986) 15.30
A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature (1986) 14.34
Direct evaluation of thermal fluctuations in proteins using a single-parameter harmonic potential. Fold Des (1997) 11.73
Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes. Nature (1980) 10.19
VENOUS PULSATION. Br J Ophthalmol (1922) 10.17
A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (1986) 8.64
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med (2000) 7.05
The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87
Domains and the hinge region of an immunoglobulin heavy chain are encoded in separate DNA segments. Nature (1979) 5.35
CERTAIN CLINICAL FEATURES OF THE NORMAL LIMBUS. Br J Ophthalmol (1934) 3.94
Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol (1998) 3.67
Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol (1990) 3.57
The role of DNA rearrangement and alternative RNA processing in the expression of immunoglobulin delta genes. Cell (1981) 2.85
Exon shuffling generates an immunoglobulin heavy chain gene. Proc Natl Acad Sci U S A (1980) 2.80
The ClpX heat-shock protein of Escherichia coli, the ATP-dependent substrate specificity component of the ClpP-ClpX protease, is a novel molecular chaperone. EMBO J (1995) 2.63
Serological studies on the cholera group of vibrios. Jpn J Med Sci Biol (1970) 2.55
Collective motions in HIV-1 reverse transcriptase: examination of flexibility and enzyme function. J Mol Biol (1999) 2.32
Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature (1997) 2.31
Stepwise activation of the immunoglobulin mu heavy chain gene locus. EMBO J (2001) 2.14
Immunoglobulin gene rearrangement in immature B cells. Science (1980) 2.14
Chemistry of single-walled carbon nanotubes. Acc Chem Res (2002) 2.10
Identification of kinetically hot residues in proteins. Protein Sci (1998) 1.82
Information-theoretical entropy as a measure of sequence variability. Proteins (1991) 1.73
Complications of cardiac catheterization in the current era: a single-center experience. Catheter Cardiovasc Interv (2001) 1.72
The alpha- and beta-tubulin folding pathways. Trends Cell Biol (1997) 1.70
Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation. J Exp Med (2000) 1.60
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
The NF-kappa B-binding site mediates phorbol ester-inducible transcription in nonlymphoid cells. Mol Cell Biol (1988) 1.54
Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood (1993) 1.50
Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J Immunol (1999) 1.48
Functional analysis of the murine T-cell receptor beta enhancer and characteristics of its DNA-binding proteins. Mol Cell Biol (1990) 1.47
Biochemical analysis of the transducin-phosphodiesterase interaction. Nat Struct Biol (1994) 1.46
"BILATERAL MESIAL SUPERFICIAL DEFICIENCY OF THE SCLERA". Br J Ophthalmol (1937) 1.45
Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export. Mol Cell Biol (2000) 1.44
Chaperonin-mediated folding of actin and tubulin. J Cell Biol (1996) 1.42
Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci (1999) 1.42
A brain-specific transcription activator. Neuron (1989) 1.41
Utility of intradermal smear in the diagnosis of malaria. Trop Doct (2003) 1.40
Linkage of the four gamma subclass heavy chain genes. Proc Natl Acad Sci U S A (1981) 1.38
Cytology and outcome of LSIL: cannot exclude HSIL compared to ASC-H. Cytopathology (2008) 1.37
Pathogenic intestinal organisms in the unfiltered water supply of Calcutta and the effect of chlorination. Indian J Med Res (1969) 1.36
Complex regulation of the immunoglobulin mu heavy-chain gene enhancer: microB, a new determinant of enhancer function. Mol Cell Biol (1990) 1.31
Extraskeletal osteochondroma in the nape of the neck: a case report. J Orthop Surg (Hong Kong) (2006) 1.30
CERTAIN CLINICAL FEATURES OF THE NORMAL LIMBUS. Br J Ophthalmol (1934) 1.27
Physiologic activation of T cells via the T cell receptor induces NF-kappa B. J Immunol (1991) 1.27
Antimicrobial potential of a lipopeptide biosurfactant derived from a marine Bacillus circulans. J Appl Microbiol (2008) 1.25
IkappaB family members function by different mechanisms. J Biol Chem (2001) 1.23
A T cell nuclear factor resembling NF-AT binds to an NF-kappa B site and to the conserved lymphokine promoter sequence "cytokine-1". J Biol Chem (1992) 1.22
Induction of the transcription factors NF-kappa B, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int Immunol (1995) 1.22
Cyclosporin-A sensitive induction of NF-AT in murine B cells. Immunity (1994) 1.22
Altered I-A protein-mediated transmembrane signaling in B cells that express truncated I-Ak protein. Proc Natl Acad Sci U S A (1989) 1.21
Structure of a psoralen-thymine monoadduct formed in photoreaction with DNA. J Mol Biol (1982) 1.20
Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J Neurosci Res (1998) 1.19
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther (2006) 1.18
Ion tolerance of Saccharomyces cerevisiae lacking the Ca2+/CaM-dependent phosphatase (calcineurin) is improved by mutations in URE2 or PMA1. Genetics (1998) 1.18
Regulation of immunoglobulin gene transcription. Int Rev Cytol (1992) 1.18
Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPalpha. Nucleic Acids Res (1998) 1.17
Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex. Biochemistry (2000) 1.13
Water removal and solute additions determining increases in renal medullary osmolality. Am J Physiol (1983) 1.13
Detection of Hong Kong 97-like H5N1 influenza viruses from eggs of Vietnamese waterfowl. Arch Virol (2006) 1.11
c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation. Immunity (1997) 1.11
Switch recombination breakpoints are strictly correlated with DNA recognition motifs for immunoglobulin S gamma 3 DNA-binding proteins. J Exp Med (1992) 1.10
Primary involvement of scrotum in tuberculoid leprosy. A case report. Indian J Lepr (1990) 1.08
Inhibition of MHC class II-restricted T cell response by Lyt-2 alloantigen. J Exp Med (1989) 1.08
FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J Exp Med (1995) 1.07
Relationships between amino acid sequence and backbone torsion angle preferences. Proteins (2004) 1.06
Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway. Proc Natl Acad Sci U S A (1994) 1.06
Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol. Eur J Clin Pharmacol (1981) 1.06
Aortic valve replacement in geriatric patients: determinants of in-hospital mortality. Ann Thorac Surg (2001) 1.05
Survival following mechanical ventilation for acute respiratory failure in adult men. Chest (1993) 1.05
The isolation and characterization of strains of cholera vibrios belonging to Heiberg groups other than group I. Indian J Med Res (1969) 1.04
PU.1 and an HLH family member contribute to the myeloid-specific transcription of the Fc gamma RIIIA promoter. EMBO J (1994) 1.04
Efficient characterization of collective motions and interresidue correlations in proteins by low-resolution simulations. Biochemistry (1997) 1.03
Intrathymic signals in thymocytes are mediated by p38 mitogen-activated protein kinase. J Immunol (1996) 1.02
Functional GATA-3 binding sites within murine CD8 alpha upstream regulatory sequences. J Exp Med (1993) 1.02
TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals. Mol Endocrinol (1995) 1.01
Differential interactions of the Mg2+ complexes of chromomycin A3 and mithramycin with poly(dG-dC) x poly(dC-dG) and poly(dG) x poly(dC). Biochemistry (1997) 1.01
Understanding the recognition of protein structural classes by amino acid composition. Proteins (1997) 1.00
A three-protein-DNA complex on a B cell-specific domain of the immunoglobulin mu heavy chain gene enhancer. J Biol Chem (1997) 1.00
Receptor-specific induction of NF-kappaB components in primary B cells. Int Immunol (1998) 1.00
Microcosm-based analyses of Scots pine seedling growth, ectomycorrhizal fungal community structure and bacterial carbon utilization profiles in boreal forest humus and underlying illuvial mineral horizons. FEMS Microbiol Ecol (2001) 1.00
Switch recombination breakpoints occur at nonrandom positions in the S gamma tandem repeat. J Immunol (1993) 1.00
Comparison between autoantibodies arising during Trypanosoma cruzi infection in mice and natural autoantibodies. J Immunol (1990) 1.00
Alteration of a single nucleotide allows efficient binding of H2TF1/KBF1 to the immunoglobulin kappa enhancer B motif. Mol Cell Biol (1989) 1.00
A second sequence element located 3' to the NF-kappa B-binding site regulates IL-2 receptor-alpha gene induction. J Immunol (1989) 0.99
The DNA-binding domain of the hexameric arginine repressor. J Mol Biol (1995) 0.98
Differential regulation of c-Rel translocation in activated B and T cells. J Immunol (1996) 0.98
Cholera carriers in a Calcutta slum. Lancet (1968) 0.98
Some observations on Vibrio cholerae strains isolated during the controlled field trial of cholera vaccines in Calcutta in 1964. Indian J Med Res (1965) 0.98
Precise alignment of sites required for mu enhancer activation in B cells. Mol Cell Biol (1996) 0.97
A critical assessment of the conventional Widal test in the diagnosis of tyhoid and parathyphoid fevers. Indian J Med Res (1969) 0.96
Transcriptional activation by ETS and leucine zipper-containing basic helix-loop-helix proteins. Mol Cell Biol (1999) 0.96
Expression and induction of nuclear factor-kappa B-related proteins in thymocytes. J Immunol (1995) 0.96
Structural characterization of the glycan part of glycoconjugate LbGp2 from Lycium barbarum L. Carbohydr Res (2001) 0.96
In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences. Mol Cell Biol (1987) 0.96
ETS-core binding factor: a common composite motif in antigen receptor gene enhancers. Mol Cell Biol (1998) 0.95